tradingkey.logo
搜尋

TELA Bio Inc

TELA
添加自選
0.706USD
-0.034-4.65%
收盤 06/26, 16:00美東報價延遲15分鐘
27.91M總市值
虧損本益比TTM

關於 TELA Bio Inc 公司

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

TELA Bio Inc簡介

公司代碼TELA
公司名稱TELA Bio Inc
上市日期Nov 08, 2019
CEOKoblish (Antony)
員工數量209
證券類型Ordinary Share
年結日Nov 08
公司地址1 Great Valley Parkway, Suite 24
城市MALVERN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編19355
電話14843202930
網址https://www.telabio.com/
公司代碼TELA
上市日期Nov 08, 2019
CEOKoblish (Antony)

TELA Bio Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
487.76K
+30.34%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
198.75K
+43.27%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
23.60K
+49.47%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+55.91%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+55.91%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+55.91%
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Roberto E. Cuca, J.D.
Mr. Roberto E. Cuca, J.D.
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
487.76K
+30.34%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
198.75K
+43.27%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
23.60K
+49.47%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+55.91%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+55.91%

常見問題

TELA Bio Inc的前五大股東是誰?

TELA Bio Inc的前五大股東如下:Mr. Antony Koblish

有多少機構持有TELA Bio Inc(TELA)的股份?

截至2026Q1,共有163家機構持有TELA Bio Inc的股份,合計持有的股份價值約為32.85M,占公司總股份的73.39% 。與2025Q4相比,機構持股有所增加,增幅為-6147477.00。

哪個業務部門對TELA Bio Inc的收入貢獻最大?

在2026Q1,OviTex業務部門對TELA Bio Inc的收入貢獻最大,創收51.22M,占總收入的63.81% 。
KeyAI